Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Amarin Corp. ADR sell IfYouCanDreamItYouCanDoIt

Start price
€3.40
15.11.21 / 60%
Target price
€2.00
31.12.23
Performance (%)
-15.88%
End price
€2.86
16.12.21
Summary
This prediction ended on 16.12.21 with a price of €2.86. The price of Amarin Corp. ADR decreased from the start of the prediction. Compared to the start price this resulted in a performance of -15.88%. IfYouCanDreamItYouCanDoIt has 60% into this prediction

Amarin Corporation plc (Symbol AMRN) is a biopharmaceutical company that is focused on the development and commercialization of therapeutics to improve cardiovascular health. The company's main product, Vascepa, is a prescription medication that has been approved by the US FDA for use as an adjunct to diet to reduce triglyceride levels in adults with severe hypertriglyceridemia. Vascepa has also shown to reduce the risk of cardiovascular events such as heart attack and stroke in patients with elevated cardiovascular risk. As a listed company, Amarin is publicly traded on the NASDAQ stock exchange and has a market capitalization of approximately $5 billion as of August 2021.

Performance without dividends (%)
Name 1w 1m 1y
Amarin Corp. ADR -11.282% -11.282% -31.890%
iShares Core DAX® -1.785% -1.250% 11.664%
iShares Nasdaq 100 -2.154% 0.300% 37.531%
iShares Nikkei 225® -4.028% -3.746% 17.142%
iShares S&P 500 -1.969% 0.307% 25.617%

According to IfYouCanDreamItYouCanDoIt what are the pros and cons of Amarin Corp. ADR for the foreseeable future?

Pros
Could be very worthwhile Investment >20% year
Cons

Comments by IfYouCanDreamItYouCanDoIt for this prediction

In the thread Amarin Corp. ADR diskutieren
Prediction Sell
Perf. (%) -15.88%
Target price 2.000
Change
Ends at 31.12.23

Sell mit Kursziel 2,0

In the thread Trading Amarin Corp. ADR
Prediction Sell
Perf. (%) -15.88%
Target price 2.000
Change
Ends at 31.12.23

Sell beendet